FERMATA
Dead / Abandoned — Abandoned — no statement of use filed (as of 31 Mar 2025)
What this means for you
This application is over — abandoned 31 Mar 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98208065
- Mark type
- Word mark
- Filed
- 03 Oct 2023
- Published for opposition
- 02 Jul 2024
- Abandoned
- 31 Mar 2025
- Attorney of record
- Susan A. Smith
Goods and services
- Class 042 — Scientific and technological services: Providing medical and scientific research information in the field of clinical trials relating to Fabry disease; Scientific research in the nature of conducting clinical trials for others in the field of Fabry disease; Pharmaceutical research and development in the field of Fabry disease
Owner
- Spark Therapeutics, Inc., Philadelphia, PA, US
- Spark Therapeutics, Inc., Philadelphia, PA, US
Prosecution history
- 31 Mar 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 31 Mar 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 27 Aug 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Jul 2024 — PUBLISHED FOR OPPOSITION
- 12 Jun 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 May 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 May 2024 — EXAMINER'S AMENDMENT ENTERED
- 29 May 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 29 May 2024 — EXAMINERS AMENDMENT E-MAILED
- 29 May 2024 — EXAMINERS AMENDMENT -WRITTEN
- 23 May 2024 — ASSIGNED TO EXAMINER
- 13 Oct 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 06 Oct 2023 — NEW APPLICATION ENTERED